This suggestion lends support from the finding, that the administration of benfotiamine (an analogon of the cofactor thiamine and transketolase activator) blocks hyperglycaemic damage and prevents experimental diabetic retinopathy in mice (Hammes et al. 2003). Here, TKT is linked to diabetic retinopathy.